Simona Halep provisionally suspended from tennis after anti-doping violation but vows to ‘fight for the truth’

Simona Halep tested positive at this year’s US Open

Sign up to our free sport newsletter for all the latest news on everything from cycling to boxing

Sign up to our free sport email for all the latest news

Thanks for signing up to the
Sport email

Simona Halep said she will “fight for the truth” after the former World No 1 and Wimbledon champion was provisionally suspended from tennis for testing positive for a banned substance at this year’s US Open.

A statement from the International Tennis Integrity Agency stated that Halep failed a doping test after her sample contained the anti-anemia medication Roxadustat, which is a prohibited substance on the World Anti-Doping Agency’s list.

Halep, a two-time grand slam champion, will be ineligible to compete in or attend any sanctioned tennis events organised by the governing bodies of the sport during her provisional suspension, the statement continued.

But in response, Halep said the news had come as the “biggest shock of my life” and vowed to “fight until the end” to clear her name. Halep said she “never knowingly took any prohibited substance”.

Roxadustat is a drug that increases oxygen-carrying capacity and is in the same category on Wada’s list of prohibited substances as EPO, another blood-boosting drug.

Recommended



Halep’s provisional ban is the most significant to hit tennis since former World No 1 Maria Sharapova was banned for 15 months for testing positive for the banned substance meldonium in 2016.

More follows

Register for free to continue reading

Registration is a free and easy way to support our truly independent journalism

By registering, you will also enjoy limited access to Premium articles, exclusive newsletters, commenting, and virtual events with our leading journalists

{{#verifyErrors}} {{message}} {{/verifyErrors}} {{^verifyErrors}} {{message}} {{/verifyErrors}}

By clicking ‘Create my account’ you confirm that your data has been entered correctly and you have read and agree to our Terms of use, Cookie policy and Privacy notice.

This site is protected by reCAPTCHA and the Google Privacy policy and Terms of service apply.

Already have an account? sign in

By clicking ‘Register’ you confirm that your data has been entered correctly and you have read and agree to our Terms of use, Cookie policy and Privacy notice.

This site is protected by reCAPTCHA and the Google Privacy policy and Terms of service apply.

Register for free to continue reading

Registration is a free and easy way to support our truly independent journalism

By registering, you will also enjoy limited access to Premium articles, exclusive newsletters, commenting, and virtual events with our leading journalists

{{#verifyErrors}} {{message}} {{/verifyErrors}} {{^verifyErrors}} {{message}} {{/verifyErrors}}

By clicking ‘Create my account’ you confirm that your data has been entered correctly and you have read and agree to our Terms of use, Cookie policy and Privacy notice.

This site is protected by reCAPTCHA and the Google Privacy policy and Terms of service apply.

Already have an account? sign in

By clicking ‘Register’ you confirm that your data has been entered correctly and you have read and agree to our Terms of use, Cookie policy and Privacy notice.

This site is protected by reCAPTCHA and the Google Privacy policy and Terms of service apply.

Source: Read Full Article